Loading...

HBIO HARVARD BIOSCIENCE INC Delisting Actions 8-K Filing

HRVR

HB

HARVARD BIOSCIENCE INC

(HBIO)

2025 8-K

Corporate Update

Financial Results Announced

Management Changes

Stock Split Approved

Financial Results Update

Operational Changes

By-law Amendment

Investor Update

Loan Agreement Details

Credit Agreement Update

Financial Results Announced

Nasdaq Compliance Update

Board Appointment

Management Change

Notice of Delisting

Financial Statements

Director Departure

Delisting Notice

Financial Results

Credit Agreement Amendment

Financial Results

Annual Meeting of Stockholders

Credit Agreement Amendment

Compensation Committee Appr...

Financial Results Announcement

Financial Condition and Res...

Appointment of CFO

Annual Meeting of Stockholders

Compensation Committee Appr...

Financial Results Announcement

Resignation of CFO

External Links:

On October 2, 2025, Harvard Bioscience, Inc. was granted an additional 180 days to meet the $1.00 minimum bid price requirement for its stock listing on Nasdaq. The stock will transfer to the Nasdaq Capital Market effective October 3, 2025, and if the company fails to meet the requirement by March 30, 2026, its stock could be delisted.

AI Assistant

HARVARD BIOSCIENCE INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.